MAPT and early-onset autosomal dominant Alzheimer disease: The importance of a defective glymphatic system in the brain accumulation of toxic amyloid-β and tau proteins has been shown in animal models (19) and suggested as an explanation for the poor efficacy of immunotherapy in patients with Alzheimer’s disease (20).